Publicaciones en las que colabora con María Jesús Bullido Gómez -Heras (17)

2019

  1. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  2. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

  3. The epistasis project: A multi-cohort study of the effects of BDNF, DBH, and SORT1 epistasis on Alzheimer's disease risk

    Journal of Alzheimer's Disease, Vol. 68, Núm. 4, pp. 1535-1547

  4. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease

    Translational Psychiatry, Vol. 9, Núm. 1

2018

  1. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 10, pp. 595-598

2016

  1. Shared genetic contribution to ischemic stroke and Alzheimer's disease

    Annals of Neurology, Vol. 79, Núm. 5, pp. 739-747

2015

  1. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671

  2. MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium

    Journal of Alzheimer's Disease, Vol. 49, Núm. 2, pp. 343-352

2014

  1. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

    Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4

2013

  1. Erratum: Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease (Molecular Psychiatry (2013) 18 (521) DOI: 10.1038/mp.2012.75))

    Molecular Psychiatry

  2. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

    Molecular Psychiatry, Vol. 18, Núm. 4, pp. 461-470

  3. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Nature Genetics, Vol. 45, Núm. 12, pp. 1452-1458

2011

  1. APOE and Alzheimer disease: A major gene with semi-dominant inheritance

    Molecular Psychiatry, Vol. 16, Núm. 9, pp. 903-907

  2. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

    Nature Genetics, Vol. 43, Núm. 5, pp. 429-436

  3. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations

    Neurobiology of Aging, Vol. 32, Núm. 4, pp. 756.e11-756.e15

2010

  1. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: A meta-analysis study

    Journal of Alzheimer's Disease, Vol. 22, Núm. 1, pp. 247-255

2009

  1. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    Nature Genetics, Vol. 41, Núm. 10, pp. 1094-1099